01 1Jiangxi Synergy Pharmaceutical
01 1CANAGLIFLOZIN HEMIHYDRATE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-01-29
Pay. Date : 2023-09-18
DMF Number : 38734
Submission : 2023-09-27
Status : Active
Type : II
20
Jiangxi Synergy Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CANAGLIFLOZIN HEMIHYDRATE, with a corresponding US DMF Number 38734.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 29, 2024, and payment made on September 18, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
